NOVODX
Urine malaria screening

Blood-free malaria screening for decentralized programs.

GoldN™ Easy-to-Use Urine Malaria Test is a urine-based malaria screening assay for public-health, community, and field deployment where blood collection and laboratory infrastructure are limited.

Not a U.S. consumer product. Not sold on areyougoldn.com.

Program at a glance
Designed for public-health screening where blood draw and lab infrastructure are limited.
Urine sample
Blood-free collection for community and field workflows
P. falciparum
Screening designed for Plasmodium falciparum malaria
Visual readout
Qualitative antigen result with a control line
Field-ready
Built for decentralized settings with limited lab infrastructure
Assay design

Urine-based malaria screening without a blood draw.

GoldN™ Easy-to-Use Urine Malaria Test supports screening programs that need a simple sample type, reduced biohazard handling, and operation outside traditional laboratories.

What stands out

Blood-free sample

Urine collection removes the need for fingerstick or venous blood in the screening workflow.

USERS
Trained program staff

Healthcare workers, NGOs, and authorized organizations.

SETTING
Field and community

Clinical, community, and limited-infrastructure sites.

READOUT
Visual qualitative

Antigen presence or absence with a control-line check.

LIMIT
Screening use

A negative result does not rule out malaria.

Test workflow

Built for simple, decentralized screening.

The workflow prioritizes minimal training burden and clear visual interpretation for program deployment.

01

Collect urine sample

Obtain the urine sample per program protocol.

02

Run the assay

Apply sample to the test cassette according to instructions.

03

Wait for development

Allow the strip to develop the control and test line pattern.

04

Read the result

Interpret the visual qualitative result. Confirmatory clinical assessment remains available when symptoms persist.

Differentiation

Blood-free sampling. Field deployment. Clear visual readout.

Built for malaria screening programs that need operational simplicity without laboratory dependency.

01

Blood-free collection

Urine sample removes phlebotomy from the screening step.

02

Decentralized use

Supports community and field sites with limited lab access.

03

Program audiences

Healthcare workers, NGOs, and institutional buyers.

04

Companion path

GoldN Companion is in development for connected workflows.

Program fit

Where urine malaria screening fits operationally.

Category comparison for procurement and program design discussions. Not a performance league table.

MetricGoldN™ Easy-to-Use Urine Malaria TestTypical blood malaria RDT
SampleUrineCapillary or venous blood
Blood collectionNot required for this assayRequired
Setting emphasisDecentralized / community / fieldClinic and community (varies by product)
Result typeVisual qualitative screenVisual qualitative screen (typical)
Primary usersProgram staff and authorized organizationsClinicians and community health workers
U.S. consumer retailNoVaries; this GoldN program is not sold as a U.S. consumer product

Sample

GoldN urine testUrine
Blood RDT (typical)Capillary or venous blood

Blood collection

GoldN urine testNot required for this assay
Blood RDT (typical)Required

Setting emphasis

GoldN urine testDecentralized / community / field
Blood RDT (typical)Clinic and community (varies by product)

Result type

GoldN urine testVisual qualitative screen
Blood RDT (typical)Visual qualitative screen (typical)

Primary users

GoldN urine testProgram staff and authorized organizations
Blood RDT (typical)Clinicians and community health workers

U.S. consumer retail

GoldN urine testNo
Blood RDT (typical)Varies; this GoldN program is not sold as a U.S. consumer product
Connected platform

GoldN Companion for connected screening programs.

GoldN™ Easy-to-Use Urine Malaria Test is a visual assay for program use. GoldN Companion is in development for connected workflows.

  • The urine malaria test can be read visually today.
  • GoldN Companion is in development and not available for sale.
  • Not cleared or approved by the FDA.
GoldN Companion

GoldN Companion video

The video shows the companion concept and the workflow direction for connected screening programs.

Program partnership

NOVODX works with public-health programs and distributors.

Governments, NGOs, and authorized organizations can request program information, evaluation supply, and procurement discussions.

Contact NOVODX
Use frame

Public-health screening outside the U.S. consumer market.

This chapter is a public-health program page. It is not a U.S. consumer product and is not sold on areyougoldn.com.

Public-health programsInstitutional evaluationContact NOVODX
FAQ

Program questions in plain clinical language.

What type of malaria does the test screen for?

The assay is designed to screen for malaria caused by Plasmodium falciparum, the species responsible for the majority of malaria cases in Africa.

What sample type does the test use?

The test uses a urine sample, eliminating the need for blood collection. This reduces biohazard risk and simplifies screening in community and decentralized settings.

Who is the intended user?

Healthcare workers, public health programs, NGOs, and authorized organizations conducting malaria screening activities. Adult supervision is required when used for children.

Where can the test be used?

Clinical, community, and field settings, including areas with limited laboratory infrastructure.

How are results interpreted?

The test provides a visual result indicating the presence or absence of malaria antigens in urine. A control line confirms proper test function. Results are qualitative and intended for screening purposes.

Does a negative result rule out malaria?

No. A negative result does not definitively rule out malaria. If symptoms persist, further clinical assessment and confirmatory testing are recommended.

How can organizations request pricing or bulk supply?

Governments, NGOs, and distributors may request pricing and availability by contacting NOVODX through this website.